Patent Expiry
Patent/Exclusivity Expiry: YCANTH
- Drug
- YCANTH
Other upcoming events for VRCA
Phase 3 ReadoutPhase 3 Topline: COVE-2: A Phase 3, Double-blind, Randomized, Vehicle-controlled Study to Evaluate the Efficacy and S
Phase 3 ReadoutPhase 3 Topline: COVE-3: A Phase 3, Double-blind, Randomized, Vehicle-controlled Study to Evaluate the Efficacy and S
Phase 3 ReadoutPhase 3 Topline: COVE-4: A Phase 3, Open-Label, Long-Term Follow-Up Study to Evaluate the Safety and Efficacy of YCAN
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.